VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 105 filers reported holding VERONA PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,891,223 | -10.1% | 130,790 | 0.0% | 0.37% | -13.5% |
| Q1 2024 | $2,104,411 | -19.1% | 130,790 | 0.0% | 0.42% | -44.0% |
| Q4 2023 | $2,600,105 | +43.2% | 130,790 | +44.6% | 0.76% | +12.7% |
| Q1 2023 | $1,816,256 | +74.0% | 90,451 | +126.4% | 0.67% | +68.6% |
| Q4 2022 | $1,043,920 | – | 39,951 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,369,000 | $47,095,720 | 7.54% |
| NEA Management Company, LLC | 5,108,563 | $111,024,890 | 7.40% |
| Vivo Capital, LLC | 4,249,918 | $84,488,370 | 6.92% |
| Aisling Capital Management LP | 1,115,352 | $22,173,198 | 6.61% |
| Rosalind Advisors, Inc. | 250,000 | $4,970,000 | 4.09% |
| First Turn Management, LLC | 1,206,291 | $23,981,065 | 3.44% |
| Knoll Capital Management, LLC | 200,000 | $3,976,000 | 3.29% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $59,925,258 | 3.20% |
| Tri Locum Partners LP | 293,112 | $5,827,067 | 2.66% |
| Carlyle Group Inc. | 2,457,500 | $48,805,950 | 2.35% |